Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs
Clinical trial NCT02907359 · COMPLETED
Trial details
- NCT number
- NCT02907359
- Sponsor
- Astex Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-13
- Primary completion
- 2020-03-31
- Enrollment
- 417
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.